Drug Profile
Atropine - Vyluma
Alternative Names: Atropine - Nevakar; NVK-002Latest Information Update: 08 Jan 2024
Price :
$50
*
At a glance
- Originator Nevakar
- Developer Nevakar; Zhaoke (Hong Kong) Ophthalmology Pharmaceutical
- Class Alkaloids; Antidotes; Cardiovascular therapies; Eye disorder therapies; Small molecules; Tropanes
- Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Myopia